Cellona Therapeutics


Launched:

2011

Management:

Wendy Tsai

Duke Inventor(s):

Patrick J. Casey

Cellona TherapeuticsTM, a pharmaceutical company focused on development and commercialization of novel targeted cancer drugs

Cellona Therapeutics, Inc. is a privately held pharmaceutical company developing and commercializing targeted therapeutics to improve survival paradigms in cancer patients. Our oncology compounds target novel signaling pathways, and have potential indications in large therapeutic markets with considerable unmet needs. Cellona Therapeutics is developing a new class of cancer drug to inhibit the RAS family of cancer proteins. Mutation and hyperactivity of RAS family members occurs in, and is a driver of, most human cancers. Our compounds offer selective inhibition of these onco-proteins that mediate and control cancer genesis and growth. For more information visit http://www.cellonatherapeutics.com

Contact: Cellona Therapeutics, Inc. Wendy Tsai, Vice President, tsaiw@cellonatherapeutics.com.